Safe Orthopaedics S.A.
ALSAF.PA · PAR
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | €3 | €3 | €3 | €3 |
| % Growth | -10.2% | -0.3% | -6.6% | – |
| Cost of Goods Sold | €3 | €1 | €0 | €5 |
| Gross Profit | -€0 | €1 | €3 | -€2 |
| % Margin | -1.7% | 48.7% | 100% | -58% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €4 | €0 | €0 | €1 |
| SG&A Expenses | €4 | €0 | €0 | €1 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | -€2 | €12 | €0 | -€0 |
| Operating Expenses | €2 | €12 | €0 | €1 |
| Operating Income | -€2 | -€11 | €3 | -€3 |
| % Margin | -78.5% | -375.3% | 100% | -86.5% |
| Other Income/Exp. Net | -€140 | -€263 | €0 | -€0 |
| Pre-Tax Income | -€142 | -€271 | €0 | -€3 |
| Tax Expense | €18 | -€66 | €0 | €0 |
| Net Income | -€160 | -€205 | -€103 | -€3 |
| % Margin | -6,130.3% | -7,081.8% | -3,531.2% | -98.3% |
| EPS | -1,791,387 | -2,706,764 | 0 | -42,300 |
| % Growth | 33.8% | – | 100% | – |
| EPS Diluted | -1,585,390 | -2,348,260 | 0 | -25,063 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | -€263 | €0 | -€0 |
| Interest Expense | €211 | €0 | €0 | -€0 |
| Depreciation & Amortization | -€0 | €3 | €0 | €1 |
| EBITDA | €70 | -€271 | €3 | -€2 |
| % Margin | 2,667.3% | -9,344.4% | 100% | -79.5% |